Dental Membrane and Bone Graft Substitutes Market Forecast by Application & Region

The global dental membrane and bone graft substitutes market was valued at USD 1.47 billion in 2024 and is projected to reach USD 2.96 billion by 2033, growing at a CAGR of 8.19% from 2025 to 2033. The market is primarily driven by the increasing prevalence of dental disorders and the rising demand for aesthetic and restorative dental procedures.

Dental tourism and growing awareness of advanced dental treatments are further propelling market growth. The rising incidence of dental conditions—including periodontal disease, tooth decay, tooth loss, and oral cancer—significantly contributes to demand for dental membranes and bone graft substitutes. According to World Health Organization (March 2025) data, over 1 billion people globally suffer from severe periodontal disease. Additionally, approximately 7% of adults aged 20+ and 23% of adults over 60 experience complete tooth loss, often necessitating implants and bone regeneration procedures. Tooth loss can lead to jawbone deterioration, highlighting the critical role of bone graft substitutes and membranes in supporting successful implant integration.

The increasing incidence of oral cancer further drives demand, as surgical treatment often requires bone grafts to reconstruct areas of the jawbone damaged or removed during tumor excision. This emphasizes the essential role of dental membranes and bone graft substitutes in ensuring successful surgical outcomes and post-operative rehabilitation.

Key Market Trends & Insights

• North America dominated the market with a 37.90% revenue share in 2024.
• By product, bone graft substitutes (BGS) are projected to grow fastest, with a CAGR of 8.92% during the forecast period.
• By application, socket preservation led the market with a 27.61% revenue share in 2024.

Download a free sample PDF of the Dental Membrane and Bone Graft Substitutes Market Intelligence Study by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.47 Billion
• 2033 Projected Market Size: USD 2.96 Billion
• CAGR (2025–2033): 8.19%
• Largest Regional Market (2024): North America
• Fastest-Growing Regional Market: Asia Pacific

Competitive Landscape

The market is moderately fragmented, with leading multinational and regional players competing to expand their presence. Companies are focusing on broadening product portfolios, obtaining regulatory approvals, and strategic collaborations to meet growing demand.

Key companies include:

• Dentsply Sirona
• Bioteck S.p.A.
• Maxigen Biotech Inc.
• Institut Straumann AG
• Nobel Biocare Services AG (Envista)
• Geistlich Holding
• ZimVie Inc.
• NovaBone (Halma)
• Osteogenics Biomedical (Envista)
• Regenity

Other notable players include Medtronic, BioHorizons, REGEDENT AG, IDL Dental Technologies LTD, EUCARE Pharmaceuticals, Curasan, TBR Dental, DentiumUSA, Tecnoss Dental Srl, Unicare Biomedical, Neoss, Advanced Medical Solutions Group plc, B&B Dental Implant Company, botiss, Septodont Holding, Implant Direct Corporation (Envista), META BIOMED CO., LTD, and SigmaGraft Biomaterials.

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.